Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Omfattende analyse

Aiforia: Promisingly started growth journey is just beginning

Aiforia Technologies
Download analyse (PDF)

Aiforia has gained a promising first foothold in the clinical segment of digital pathology. We continue to see the company in a good competitive position and on a clear trajectory to grow into one of the long-term winners in its market. On the other hand, poor growth predictability and elevated financing risks argue for some caution in pricing the company's potential. However, at the current share price, we believe that the company's value creation potential outweighs the risks.

Aiforia Technologies

3,45EUR28.02.2024, 18.00
4,20EURKursmål
Akkumulér
Ændret fra:Akkumulér
Anbefaling opdateret:28.02.2024

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures28.02.2024

202223e24e
Omsætning1,62,54,5
vækst-%64,9 %56,2 %79,2 %
EBIT (adj.)-11,8-12,6-11,2
EBIT-% (adj.)-731,9 %-502,9 %-248,7 %
EPS (adj.)-0,47-0,50-0,43
Udbytte0,000,000,00
Udbytte %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team